Advanced Glycation End Products Alter the M⁶A-Modified RNA Profiles in Human Dermal Fibroblasts

References

• Poon F , KangS , ChienAL. Mechanisms and treatments of photoaging. Photodermatol. Photoimmunol. Photomed.31(2), 65–74 (2015).
   PubMed Web of Science ®Google Scholar
• Jeanmaire C , DanouxL , PaulyG. Glycation during human dermal intrinsic and actinic ageing: an in vivo and in vitro model study. Br. J. Dermatol.145(1), 10–18 (2001).
   PubMed Web of Science ®Google Scholar
• Gkogkolou P , BöhmM. Advanced glycation end products: key players in skin aging?Dermatoendocrinology4(3), 259–270 (2012).
   PubMedGoogle Scholar
• Maity A , DasB. N6-methyladenosine modification in mRNA: machinery, function and implications for health and diseases. FEBS J.283, 1607–1630 (2016).
   PubMed Web of Science ®Google Scholar
• Dominissini D , Moshitch-MoshkovitzS , SchwartzSet al. Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq. Nature485, 201–206 (2012).
   PubMed Web of Science ®Google Scholar
• Roignant J-Y , SollerM. m6A in mRNA: an ancient mechanism for fine-tuning gene expression. Trends Genet.33(6), 380–390 (2017).
   PubMed Web of Science ®Google Scholar
• Roundtree IA , EvansME , PanT , HeC. Dynamic RNA modifications in gene expression regulation. Cell169(7), 1187–1200 (2017).
   PubMed Web of Science ®Google Scholar
• Wu Z , ShiY , LuMet al. METTL3 counteracts premature aging via m6A-dependent stabilization of MIS12 mRNA. Nucleic Acids Res.48, 11083–11096 (2020).
   PubMed Web of Science ®Google Scholar
• Min K-W , ZealyRW , DavilaSet al. Profiling of m6A RNA modifications identified an age-associated regulation of AGO2 mRNA stability. Aging Cell17, e12753 (2020).
   Web of Science ®Google Scholar
• Molinari J , RuszovaE , VelebnyV , RobertL. Effect of advanced glycation endproducts on gene expression profiles of human dermal fibroblasts. Biogerontology9, 177 (2020).
   Google Scholar
• Robinson M , ShahP , CuiY-H , HeY-Yg. Special issue invited review: the role of dynamic m6A RNA methylation in photobiology. Photochem. Photobiol.95(1), 95–104 (2019).
   PubMed Web of Science ®Google Scholar
• Fu Y , DominissiniD , RechaviG , HeC. Gene expression regulation mediated through reversible m6A RNA methylation. Nat. Rev. Genet.15(5), 293–306 (2014).
   PubMed Web of Science ®Google Scholar
• Xu X , ZhengY , HuangYet al. Cathepsin D contributes to the accumulation of advanced glycation end products during photoaging. J. Dermatol. Sci.90(3), 263–275 (2018).
   PubMed Web of Science ®Google Scholar
• Crisan M , TaulescuM , CrisanDet al. Expression of advanced glycation end-products on sun-exposed and nonexposed cutaneous sites during the ageing process in humans. PLoS ONE8(10), e75003 (2013).
   PubMed Web of Science ®Google Scholar
• Xu QF , ZhengY , ChenJet al. Ultraviolet A enhances cathepsin L expression and activity via JNK pathway in human dermal fibroblasts. Chin. Med. J. (Engl.)129(23), 2853–2860 (2016).
   PubMed Web of Science ®Google Scholar
• Wondrak GT , RobertsMJ , JacobsonMKet al. Photosensitized growth inhibition of cultured human skin cells: mechanism and suppression of oxidative stress from solar irradiation of glycated proteins. J. Invest. Dermatol.119, 489–498 (2002).
   PubMed Web of Science ®Google Scholar
• Serban IA , CostacheM , DinischiotuA. AGEs and glucose levels modulate type I and III procollagen mRNA synthesis in dermal fibroblasts cells culture. Exp. Diabetes Res.2008, 473603 (2008).
   PubMedGoogle Scholar
• Xiang Y , LaurentB , HsuC-Het al. RNA m6A methylation regulates the ultraviolet-induced DNA damage response. Nature543, 573–576 (2017).
   PubMed Web of Science ®Google Scholar
• Fazi F , FaticaA. Interplay between N6-methyladenosine (m6A) and non-coding RNAs in cell development and cancer. Front. Cell Dev. Biol.7, 116 (2019).
   PubMed Web of Science ®Google Scholar
• Yue Y , LiuJ , HeC. RNA N6-methyladenosine methylation in post-transcriptional gene expression regulation. Genes Dev.29, 1343–1355 (2015).
   PubMed Web of Science ®Google Scholar
• Jian D , WangY , JianLet al. METTL14 aggravates endothelial inflammation and atherosclerosis by increasing FOXO1 N6-methyladeosine modifications. Theranostics10, 8939–8956 (2020).
   PubMed Web of Science ®Google Scholar
• Xu Y , YuanXD , WuJJet al. The N6-methyladenosine mRNA methylase METTL14 promotes renal ischemic reperfusion injury via suppressing YAP1. J. Cell. Biochem.121(1), 524–533 (2020).
   PubMed Web of Science ®Google Scholar
• Weng H , HuangH , WuHet al. METTL14 inhibits hematopoietic stem/progenitor differentiation and promotes leukemogenesis via mRNA m6A modification. Cell Stem Cell22(2), 191–205.e9 (2018).
   PubMed Web of Science ®Google Scholar
• Ma JZ , YangF , ZhouCCet al. METTL14 suppresses the metastatic potential of hepatocellular carcinoma by modulating N6-methyladenosine-dependent primary microRNA processing. Hepatology65(2), 529–543 (2017).
   PubMed Web of Science ®Google Scholar
• Yang Z , YangS , CuiY-Het al. METTL14 facilitates global genome repair and suppresses skin tumorigenesis. Proc. Natl Acad. Sci. USA118(35), e2025948118 (2021).
   PubMed Web of Science ®Google Scholar
• Tan X , GuoW , PengZet al. LncRNA-Malat1 promoting inflammatory response aggravates cerebral ischemia-reperfusion neuronal injury in rats by targeting miR-211-5p. Biochem. Pharmacol.192, 114694 (2021).
   PubMedGoogle Scholar
• Wei L , LiJ , HanZ , ChenZ , ZhangQ. Silencing of lncRNA MALAT1 prevents inflammatory injury after lung transplant ischemia-reperfusion by downregulation of IL-8 via p300. Mol. Ther. Nucleic Acids18, 285–297 (2019).
   PubMedGoogle Scholar
• Geicu OI , StancaL , VoicuSNet al. Dietary AGEs involvement in colonic inflammation and cancer: insights from an in vitro enterocyte model. Sci. Rep.10, 2754 (2020).
   PubMed Web of Science ®Google Scholar
• Lohwasser C , NeureiterD , WeigleB , KirchnerT , SchuppanD. The receptor for advanced glycation end products is highly expressed in the skin and upregulated by advanced glycation end products and tumor necrosis factor-alpha. J. Invest. Dermatol.126, 291–299 (2006).
   PubMed Web of Science ®Google Scholar
• Zhu P , RenM , YangC , HuY-X , RanJ-M , LiY. Involvement of RAGE, MAPK and NF-κB pathways in AGEs-induced MMP-9 activation in HaCaT keratinocytes. Exp. Dermatol.21, 123–129 (2012).
   PubMed Web of Science ®Google Scholar
• Serban AI , StancaL , GeicuOI , MunteanuMC , CostacheM , DinischiotuA. Extracellular matrix is modulated in advanced glycation end products milieu via a RAGE receptor dependent pathway boosted by transforming growth factor-β1 RAGE. J. Diabetes7, 114–124 (2015).
   PubMed Web of Science ®Google Scholar
• Serban AI , StancaL , GeicuOI , MunteanuMC , DinischiotuA. RAGE and TGF-β1 cross-talk regulate extracellular matrix turnover and cytokine synthesis in AGEs exposed fibroblast cells. PLoS ONE11, e0152376 (2016).
   PubMed Web of Science ®Google Scholar
• Lu Z , LiuH , SongNet al. METTL14 aggravates podocyte injury and glomerulopathy progression through N-methyladenosine-dependent downregulating of Sirt1. Cell Death Dis.12, 881 (2021).
   PubMed Web of Science ®Google Scholar
• Li M , DengL , XuG. METTL14 promotes glomerular endothelial cell injury and diabetic nephropathy via m6A modification of α-klotho. Mol. Med.27, 106 (2021).
   PubMed Web of Science ®Google Scholar
• Zhang F , BankerG , LiuXet al. The novel function of advanced glycation end products in regulation of MMP-9 production. J. Surg. Res.171, 871–876 (2011).
   PubMed Web of Science ®Google Scholar
• Lu W , LiJ , RenMet al. Role of the mevalonate pathway in specific CpG site demethylation on AGEs-induced MMP9 expression and activation in keratinocytes. Mol. Cell. Endocrinol.411, 121–129 (2011).
   Google Scholar
• Decean H , Perde-SchreplerM , TatomirC , Fischer-FodorE , BrieI , ViragP. Modulation of the pro-inflammatory cytokines and matrix metalloproteinases production in co-cultivated human keratinocytes and melanocytes. Arch. Dermatol. Res.305, 705–714 (2013).
   PubMed Web of Science ®Google Scholar
• Lang J , YangC , LiuLet al. High glucose activates ERK1/2 to stabilize AP1 and increase MMP9 expression in diabetic foot ulcers. Exp. Cell Res.403, 112550 (2021).
   PubMed Web of Science ®Google Scholar
• Rodríguez D , MorrisonCJ , OverallCM. Matrix metalloproteinases: what do they not do? New substrates and biological roles identifed by murine models and proteomics. Biochim. Biophys. Acta1803(1), 39–54 (2010).
   PubMed Web of Science ®Google Scholar
• Vempati P , KaragiannisED , PopelAS. A biochemical model of matrix metalloproteinase 9 activation and inhibition. J. Biol. Chem.282(52), 37585–37596 (2007).
   PubMed Web of Science ®Google Scholar
• Altonsy MO , SasseSK , PhangTL , GerberAN. Context-dependent cooperation between nuclear factor κB (NF-κB) and the glucocorticoid receptor at a TNFAIP3 intronic enhancer: a mechanism to maintain negative feedback control of inflammation. J. Biol. Chem.289, 8231–8239 (2014).
   PubMed Web of Science ®Google Scholar
• Vereecke L , BeyaertR , van LooG. Genetic relationships between A20/TNFAIP3, chronic inflammation and autoimmune disease. Biochem. Soc. Trans.39, 1086–1091 (2011).
   PubMed Web of Science ®Google Scholar
• Verstrepen L , VerhelstK , van LooG , CarpentierI , LeySC , BeyaertR. Expression, biological activities and mechanisms of action of A20 (TNFAIP3). Biochem Pharmacol.80, 2009–2020 (2010).
   PubMed Web of Science ®Google Scholar
• Smith MA , Culver-CochranAE , AdelmanERet al. TNFAIP3 plays a role in aging of the hematopoietic system. Front. Immunol.11, 536442 (2020).
   PubMed Web of Science ®Google Scholar
• Chen Y , WuW , LiXet al. A20 down-regulation promotes UVB-induced inflammation via activation of the NF-κB pathway. J. Dermatol. Sci.98, 61–64 (2020).
   PubMed Web of Science ®Google Scholar
• Shrikhande GV , ScaliST , da SilvaCGet al. O-glycosylation regulates ubiquitination and degradation of the anti-inflammatory protein A20 to accelerate atherosclerosis in diabetic ApoE-null mice. PLoS ONE5, e14240 (2010).
   PubMed Web of Science ®Google Scholar
• Xu Q , HouW , ZhengYet al. Ultraviolet A-induced cathepsin K expression is mediated via MAPK/AP-1 pathway in human dermal fibroblasts. PLoS ONE9, e102732 (2014).
   PubMed Web of Science ®Google Scholar
• Ham SA , KangES , LeeHet al. PPARδ inhibits UVB-induced secretion of MMP-1 through MKP-7-mediated suppression of JNK signaling. J. Invest. Dermatol.133(11), 2593–2600 (2013).
   PubMed Web of Science ®Google Scholar
• Dai J , ChenH , ChaiY. Advanced glycation end products (AGEs) induce apoptosis of fibroblasts by activation of NLRP3 inflammasome via reactive oxygen species (ROS) signaling pathway. Med. Sci. Monit.25, 7499–7508 (2019).
   PubMed Web of Science ®Google Scholar